Integrin targeting using RGD-PEI conjugates for in vitro gene transfer

Journal of Gene Medicine

Volumn 5, Issue 7, 2003, Pages 588-599

  Kunath, Klaus ^a   Merdan, Thomas ^a   Hegener, Oliver ^a   Häberlein, Hanns ^a   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Gene delivery; Integrins; PEG; Polyethylenimine; RGD peptides; Targeting

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; DNA; ETHIDIUM BROMIDE; INTEGRIN; LIGAND; LUCIFERASE; MACROGOL; NITROGEN; PHOSPHATE; POLYETHYLENEIMINE; REAGENT; TETRAPEPTIDE; VITRONECTIN RECEPTOR; ARGINYL-GLYCYL-ASPARTIC ACID; CARRIER PROTEIN; MACROGOL DERIVATIVE; OLIGOPEPTIDE;

ARTICLE; CARCINOMA CELL; CELL SURFACE; CHEMICAL MODIFICATION; COMPARATIVE STUDY; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CONJUGATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; LUNG CARCINOMA; MEDICAL INSTRUMENTATION; MELANOMA CELL; NONVIRAL GENE DELIVERY SYSTEM; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REPORTER GENE; SUBSTITUTION REACTION; ZETA POTENTIAL; ANIMAL; CELL CULTURE; EVALUATION; GENE TARGETING; GENE VECTOR; GENETICS; METABOLISM; MOUSE; PLASMID; STRUCTURE ACTIVITY RELATION;

ANIMALS; CARRIER PROTEINS; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTEGRINS; MICE; OLIGOPEPTIDES; PLASMIDS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0141715047     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.382     Document Type: Article

References (45)

1. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995; 92: 7297-7301.
2. Goula D, Benoist C, Mantero S, et al. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther 1998; 5: 1291-1295.
3. Leonetti JP, Degols G, Lebleu B. Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake. Bioconjug Chem 1990; 1: 149-153.
4. Kircheis R, Kichler A, Wallner G, et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 1997; 4: 409-418.
5. Li S, Tan YD, Viroonchatapan E, et al. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol-Lung Cell Mol Physiol 2000; 278: L504-L511.
6. Zanta MA, Boussif O, Adib A, et al. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug Chem 1997; 8: 839-844.
7. Diebold SS, Lehrmann H, Kursa M, et al. Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection. Hum Gene Ther 1999; 10 775-786.
8. Blessing T, Kursa M, Holzhauser R, et al. Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug Chem 2001; 12: 529-537.
9. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
10. Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol 1996; 8: 724-730.
11. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996; 12: 697-715.
12. Logan D, Abu-Ghazaleh R, Blakemore W, et al. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 1993; 362: 566-568.
13. Isberg RR. Discrimination between intracellular uptake and surface adhesion of bacterial pathogens. Science 1991; 252: 934-938.
14. Hart SL, Harbottle RP, Cooper R, et al. Gene delivery and expression mediated by an integrin-binding peptide. Gene Ther 1995; 2: 552-554.
15. Erbacher P, Remy JS, Behr JP. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther 1999; 6: 138-145.
16. Plank C, Mechtler K, Szoka FC, et al. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 1996; 7: 1437-1446.
17. Ogris M, Brunner S, Schueller S, et al. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595-605.
18. Kunath K, Harpe Av, Petersen H, et al. The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-kB decoy in mice. Pharm Res 2002; 19: 810-817.
19. Ogris M, Steinlein P, Carotta S, et al. DNA/polyethylenimine transfection particles: influence of ligands, polymer size, and PEGylation on internalization and gene expression. AAPS Pharm Sci 2001; 3: article 21.
20. Hermanson GT. Bioconjugate Techniques. Academic Press: San Diego, 1996.
21. Snyder SL, Sobocinski PZ. An improved 2,4,6-trinitrobenzene-sulfonic acid method for the determination of amines. Anal Biochem 1975; 64: 284-288.
22. Harpe Av, Petersen H, Li Y, et al. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J Controlled Release 2000; 69: 309-322.
23. Petersen H, Kunath K, Martin AL, et al. Star-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines. Biomacromolecules 2002; 3: 926-936.
24. Tang MX, Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther 1997; 4: 823-832.
25. Kunath K, Harpe Av, Fischer D, et al. Galactose-PEI/DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency, J Controlled Release 2002; in print.
26. Boonen G, Pramanik A, Rigler R, et al. Evidence for specific interactions between kavain and human cortical neurons monitored by fluorescence correlation spectroscopy. Planta Med 2000; 66 7-10.
27. Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. J Soc Indust Appl Math 1963; 11: 431-441.
28. Merdan T, Kunath K, Fischer D, et al. Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm Res 2002; 19: 140-146.
29. Hill HD, Straka JG. Protein determination using bicinchoninic acid in the presence of sulfhydryl reagents. Anal Biochem 1988; 170: 203-208.
30. Li L, Tsai SW, Anderson AL, et al. Vinyl sulfone bifunctional derivatives of DOTA allow sulfhydryl- or amino-directed coupling to antibodies. Conjugates retain immunoreactivity and have similar biodistributions. Bioconjug Chem 2002; 13: 110-115.
31. Sagara K, Kim SW. A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. J Controlled Release 2002; 79: 271-281.
32. Lerman LS. A transition to a compact form of DNA in polymer solutions. Proc Natl Acad Sci U S A 1971; 68: 1886-1890.
33. Ogris M, Steinlein P, Kursa M, et al. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther 1998; 5: 1425-1433.
34. Petersen H, Fechner PM, Martin AL, et al. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem 2002; 13: 845-854.
35. Nguyen HK, Lemieux P, Vinogradov SV, et al. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther 2000; 7: 126-138.
36. Erbacher P, Bettinger T, Belguise-Valladier P, et al. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med 1999; 1: 210-222.
37. Mislick KA, Baldeschwieler JD. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci U S A 1996; 93: 12 349-12 354.
38. Nakane S, Matsumoto S, Takakura Y, et al. The accumulation mechanism of cationic mitomycin C-dextran conjugates in the liver: in-vivo cellular localization and in-vitro interaction with hepatocytes. J Pharm Pharmacol 1988; 40: 1-6.
39. Wohland T, Friedrich K, Hovius R, et al. Study of ligand-receptor interactions by fluorescence correlation spectroscopy with different fluorophores: evidence that the homopentameric 5-hydroxytryptamine type 3As receptor binds only one ligand. Biochemistry 1999; 38: 8671-8681.
40. Guo W, Lee RJ. Receptor-targeted gene delivery via folate-conjugated polyethylenimine. AAPS PharmSci 1999; 1: article 19.
41. Woodle MC, Scaria P, Ganesh S, et al. Sterically stabilized polyplex: ligand-mediated activity. J Controlled Release 2001; 74: 309-311.
42. Suh W, Han SO, Yu L, et al. An angiogenic, endothelial-cell-targeted polymeric gene carrier. Mol Ther 2002; 6: 664-672.
43. Lee H, Kim TH, Park TG. A receptor-mediated gene delivery system using streptavidin and biotin-derivatized, pegylated epidermal growth factor. J Controlled Release 2002; 83: 109-119.
44. Torchilin VP, Omelyanenko VG, Papisov MI, et al. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1994; 1195: 11-20.
45. Kornberg LJ, Earp HS, Turner CE, et al. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins. Proc Natl Acad Sci U S A 1991; 88: 8392-8396.